How physiologically based pharmacokinetic models should be improved for drug development

被引:1
|
作者
Hempel, Georg [1 ]
机构
[1] Westfal Wilheims Univ Munster, Inst Pharmazeut & Med Chem, Klin Pharm, Corrensstr 48, D-48149 Munster, Germany
关键词
antimicrobial drugs; drug development; drug metabolism; infectious disease therapeutics; pharmacokinetics/pharmacodynamics; pharmacology; systems biology; A-PRIORI; KINETICS;
D O I
10.4155/fmc-2020-0074
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:1107 / 1109
页数:3
相关论文
共 50 条
  • [1] Physiologically Based Pharmacokinetic Models Are Effective Support for Pediatric Drug Development
    Wang, Kefei
    Jiang, Kun
    Wei, Xiaoyi
    Li, Yulan
    Wang, Tiejie
    Song, Yang
    AAPS PHARMSCITECH, 2021, 22 (06)
  • [2] Physiologically Based Pharmacokinetic Models Are Effective Support for Pediatric Drug Development
    Kefei Wang
    Kun Jiang
    Xiaoyi Wei
    Yulan Li
    Tiejie Wang
    Yang Song
    AAPS PharmSciTech, 22
  • [3] Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection
    Theil, FP
    Guentert, TW
    Haddad, S
    Poulin, P
    TOXICOLOGY LETTERS, 2003, 138 (1-2) : 29 - 49
  • [4] Physiologically based pharmacokinetic modeling as a tool for drug development
    Charnick, SB
    Kawai, R
    Nedelman, JR
    Lemaire, M
    Niederberger, W
    Sato, H
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1995, 23 (02): : 217 - 229
  • [5] Use of physiologically based pharmacokinetic (PBPK) models to support canine drug product development
    Pade, D.
    Martinez, M.
    Mistry, B.
    Jamei, M.
    Rostami-Hodjegan, A.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 : 96 - 96
  • [6] Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
    Edginton, Andrea N.
    Theil, Frank-Peter
    Schmitt, Walter
    Willmann, Stefan
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (09) : 1143 - 1152
  • [7] How to link biomarkers using physiologically based pharmacokinetic models
    Boutouyrie-Dumont, Bruno
    BIOMARKERS IN MEDICINE, 2014, 8 (01) : 74 - 74
  • [8] Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug Development
    Rioux, Nathalie
    Waters, Nigel J.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (07) : 934 - 943
  • [9] Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
    Maharaj, A. R.
    Edginton, A. N.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2014, 3 (11):
  • [10] Physiologically based pharmacokinetic modeling as a tool for drug development - Commentary
    Ludden, TM
    Gillespie, WR
    Bachman, WJ
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1995, 23 (02): : 231 - 235